Big Pink

CG Results Healthcare advises Big Pink on its acquisition by precisioneffect

CG Results Healthcare is delighted to announce that it has advised Big Pink, a leading European multichannel marketing healthcare agency recognized for providing strategically designed and creatively delivered campaigns to the pharmaceutical industry worldwide, on its acquisition by precisioneffect, the healthcare advertising agency dedicated to working with companies that seek to change the standard of care. The acquisition marks an important expansion of precisioneffect’s global footprint and employee base, and positions the company to provide its clients with additional value through enhanced services and expertise.

Founded in 1992, Big Pink delivers pragmatic multichannel marketing campaigns and consultancy with a creative edge. The company has a consistent record of growth and long-tenured client relationships. One of Big Pink’s signature campaigns was a flu-awareness campaign for GlaxoSmithKline (GSK), one of the world’s largest providers of vaccines, which was executed in diverse markets. The agency is also a Level 4 Veeva partner, working with top pharmaceutical companies to provide content, optimization, and the global adoption of Veeva products.

Headquartered in Windsor, UK, Big Pink is led by founders, Chief Executive Officer Wayne Page and Creative Director Simon Wilson. Page and Wilson will join Morgan and precisioneffect’s leadership team to focus on new market opportunities and overall business development. With the addition of Big Pink, precisioneffect has 175 marketing professionals across Boston, Chicago, Costa Mesa, and London to deliver essential global go-to-market strategies for their healthcare clients.